New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 24, 2012
09:04 EDTVTRVentas, Atria management to jointly own Atria Senior Living
Ventas has executed a transaction whereby Ventas and the management team of Atria Senior Living own 100% of Atria, effective December 21. Atria’s Chairman and CEO John A. Moore will continue to lead Atria. In the transaction, Ventas acquired 100% of various private investment funds previously managed by Lazard Frères Real Estate Investors LLC or its affiliates. The acquired Funds now own (a) a 34% interest in Atria and (b) 3.7 million shares of Ventas common stock. The total purchase price for these interests was approximately $242M. Atria’s executives and employees, including Moore, now own 66% of Atria. In the transaction, Ventas also extinguished its obligation related to the “Earnout,” a contingent performance-based payment arising out of Ventas’s 2011 acquisition of 117 Atria-managed senior living communities, for an additional $44M.
News For VTR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
17:14 EDTVTRVentas approves spin-off of most SNF portfolio into Care Capital Properties
Subscribe for More Information
July 27, 2015
10:00 EDTVTROn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ADT Corp. (ADT) upgraded to Buy from Neutral at Citi... AGCO (AGCO) upgraded to Neutral from Sell at Goldman... Anthem (ANTM) upgraded to Buy from Neutral at Sterne Agee CRT... BNP Paribas (BNPQY) upgraded to Buy from Neutral at Goldman... Biogen (BIIB) upgraded on valuation at Bernstein... Box (BOX) upgraded to Overweight from Sector Weight at Pacific Crest... Capital One (COF) upgraded to Buy from Outperform at CLSA... Centene (CNC) upgraded to Buy from Neutral at UBS... Chesapeake (CHK) upgraded on potential sale of assets or company at SunTrust... Cigna (CI) upgraded to Buy from Neutral at Sterne Agee CRT... Deere (DE) upgraded to Neutral from Sell at Goldman... First BanCorp (FBP) upgraded to Buy from Neutral at Guggenheim... Flotek (FTK) upgraded on stronger demand at Oppenheimer... Lear (LEA) upgraded to Buy from Hold at Deutsche Bank... Methanex (MEOH) upgraded to Outperform from Sector Perform at Scotia Howard Weil... News Corp. (NWSA) upgraded to Outperform from Neutral at Macquarie... NextEra Energy Partners (NEP) upgraded to Outperform at Wells Fargo... OFG Bancorp (OFG) upgraded to Buy from Neutral at Guggenheim... PennyMac Mortgage (PMT) upgraded to Buy from Neutral at Compass Point... Pool Corp. (POOL) upgraded to Outperform from Market Perform at William Blair... Popular (BPOP) upgraded to Buy from Neutral at Guggenheim... Qualcomm (QCOM) upgraded to Overweight from Equal Weight at Morgan Stanley... Quality Systems (QSII) upgraded on valuation at RBC Capital... VF Corp. (VFC) upgraded to Buy from Neutral at Goldman... Ventas (VTR) upgraded on valuation, positive catalysts at BMO Capital... Weatherford (WFT) upgraded to Equal Weight from Underweight at Barclays... SS&C (SSNC) upgraded to Buy from Hold at Sandler O'Neill... Chemung Financial (CHMG) upgraded to Buy from Hold at Sandler O'Neill... Cameron (CAM) upgraded to Buy from Accumulate at Global Hunter.
08:33 EDTVTRVentas upgraded on valuation, positive catalysts at BMO Capital
As noted earlier, BMO Capital upgraded Ventas to Outperform from Market Perform. The firm upgraded the stock on valuation, its belief that the spinoff of CCP will be a catalyst for the stock, the increase in Ventas' disposition activity, and Ventas' formation of a joint venture based on Ardent's operations. Target $74.
06:16 EDTVTRVentas upgraded to Outperform from Market Perform at BMO Capital
Subscribe for More Information
July 24, 2015
07:51 EDTVTRVentas expects CCP Spin-off to close in Q3
In connection with Ventas’s previously announced plan to spin off most of its skilled nursing facility portfolio into an independent, publicly traded REIT named Care Capital Properties, CCP filed Amendment No. 2 to its Form 10 registration statement relating to the Spin-Off with the Securities and Exchange Commission on July 15, 2015. The transaction is expected to be completed in August 2015, subject to applicable approvals.
07:47 EDTVTRVentas raises FY15 normalized FFO view to $4.70-$4.76 from $4.67-$4.75
Consensus $4.66. The updated guidance range represents 5%-6% growth in normalized FFO per share over 2014. Ventas currently expects its 2015 NAREIT FFO per diluted share to increase to a range between $4.51-$4.61.
07:46 EDTVTRVentas reports Q2 normalized FFO $1.18, consensus $1.16
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use